Ex­pect­ed mis­takes, the need for speed, and change to come: CBER's Pe­ter Marks looks ahead

In a wide-rang­ing Nov. 6 dis­cus­sion with the pres­i­dent and CEO of the Friends of Can­cer Re­search, Jeff Allen, CBER di­rec­tor Marks spoke to tem­per­ing pub­lic ex­pec­ta­tion, sus­tain­ing CBER staff de­spite a crush­ing work­load dur­ing the coro­n­avirus pan­dem­ic, and the pos­si­bil­i­ty of more changes in 2021.

Un­der a new ad­min­is­tra­tion, said Marks, speak­ing at a vir­tu­al ses­sion of Bio­Phar­ma Con­gress 2020, much could change. “So my hope is that we’ve al­ready start­ed the foun­da­tion for what needs to hap­pen here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.